Willem et al. showed that in recipients undergoing a haplo-HSCT with PTCy, NKp46 + 2B4 + NK subset evolution is faster in recipients developing GVHD or those with KIR-HLA mismatch than in those patients with relapse occurrence. Here, KIR3DL1 is linked to graft versus host disease.